Table 4.

Summary of outcomes for liver transplantation for neuroendocrine metastases.

Author, publication year	Number of liver transplant (LT) patients	Survival data	Predictors of survival
Gedaly et al., 2011 [34]	150 (13 receiving another organ at time of LT)	49% 5-year survival	Improved survival with patients waiting more than 2 months for transplant (P = .005), esp. in patients >55 years old
Mathe et al., 2011 [35]	89	44% 5-year survival	0% survival if >55 years old undergoing simultaneous pancreatic resection
Le Treut et al., 2008 [36]	85 (34 with concurrent extrahepatic resection)	Median OS: 56 months	Exenteration, duodeno-pancreatic primary, and hepatomegaly were indicators of poor prognosis (all RR of death > 2.6)
Rosenau et al., 2002 [37]	19	50% 10-year survival	Ki-67 <5% and normal E-cadherin expression had 100% 7-year survival